Cushing’s Disease: The Relevance of a Combined Dexamethasone Desmopressin Test as a Component of Postoperative Hormonal Evaluation
Background. The risk of Cushing’s disease (CD) recurring may persist for years, even after initially successful surgery. Objective. To prospectively assess the relevance of a combined dexamethasone desmopressin test (CDDT) as a component of postoperative hormonal evaluation, including the dynamics o...
Saved in:
| Main Authors: | Przemysław Witek, Grzegorz Zieliński, Katarzyna Szamotulska |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2015/357165 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nonsuppressible Oral Dexamethasone Suppression Tests but Not Cushing Syndrome
by: Abilash Nair, et al.
Published: (2016-01-01) -
Desmopressin Acetate in Intracranial Haemorrhage
by: Thomas Kapapa, et al.
Published: (2014-01-01) -
History of clinical applications of desmopressin
by: Lennox R. Ksido, et al.
Published: (2024-12-01) -
Pasireotide-induced hyperglycemia in Cushing’s disease and Acromegaly: A clinical perspective and algorithms proposal
by: Przemysław Witek, et al.
Published: (2024-12-01) -
Growing threat of self-medication: Chronic dexamethasone injections and exogenous cushing’s syndrome
by: Ashok K. Pannu, et al.
Published: (2025-07-01)